Novartis
NVS
NVS
1,333 hedge funds and large institutions have $12.9B invested in Novartis in 2024 Q4 according to their latest regulatory filings, with 156 funds opening new positions, 419 increasing their positions, 465 reducing their positions, and 106 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
15% less capital invested
Capital invested by funds: $15.2B → $12.9B (-$2.28B)
24% less call options, than puts
Call options by funds: $190M | Put options by funds: $250M
31% less funds holding in top 10
Funds holding in top 10: 13 → 9 (-4)
Holders
1,333
Holding in Top 10
9
Calls
$190M
Puts
$250M
Top Buyers
| 1 | +$60.1M | |
| 2 | +$50.8M | |
| 3 | +$43.3M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$42.6M |
| 5 |
Renaissance Technologies
New York
|
+$39.3M |
Top Sellers
| 1 | -$128M | |
| 2 | -$105M | |
| 3 | -$94.8M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$44.3M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$37.5M |